Skip to main content
. 2016 Feb 9;7(14):17711–17725. doi: 10.18632/oncotarget.7293

Figure 2. Boxplot comparing the number of predicted neoantigenes between good and poor-prognosis tumors.

Figure 2

P-value was calculated using Man-Whitney U test.